State of provision of Hearing Aids in Europe

Similar documents
Cross Border Genetic Testing for Rare Diseases

The health economic landscape of cancer in Europe

European Collaboration on Dementia. Luxembourg, 13 December 2006

European Status report on Alcohol and Health

Emerging Risks Mapping of Activities in Member States. 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018

European Standard EN 15927:2010 Services offered by hearing aid professionals. Creating a barrier-free Europe for all hard of hearing citizens

Nutrient profiles for foods bearing claims

European Community Pharmacy: a reference in Public Health

What can we learn from hearing impaired people? Stockholm, April 3, European Hearing Instrument Manufacturers Associa5on

Smokefree Policies in Europe: Are we there yet?

WCPT COUNTRY PROFILE December 2017 HUNGARY

WCPT COUNTRY PROFILE December 2017 SWEDEN

Overview of drug-induced deaths in Europe - What does the data tell us?

WCPT COUNTRY PROFILE December 2017 SERBIA

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS

European status report on alcohol and health Leadership, awareness and commitment

508 the number of suicide deaths in deaths per 100,000 people was the suicide rate in Suicide deaths in 2013 by gender

UK bowel cancer care outcomes: A comparison with Europe

Clinical Evidence in the Daily Work of an Anthroposophic Hospital Dr. med. Harald Matthes, Medical Director, Havelhöhe Hospital in Berlin

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

Louisville '19 Attachment #69

Sign Language Act in Europe and Hungary by dr. Ádám Kósa

MNPS Hearing Service Plan Employee Booklet 2015 HEAR BETTER LIVE FULLY. epichearing.com

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

LEBANON. WCPT COUNTRY PROFILE December 2018

Palliative nursing care of children and young people across Europe

TEDDY. Teddy Network of Excellence. Annagrazia ALTAVILLA. Ph.D. Sciences Ethics LL.M. Health Law. diterranée

DENMARK. WCPT COUNTRY PROFILE December 2018

WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017

Extrapolation and potential impact of IPHS deployment in Europe

Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe

Joint Programming in Neurodegenerative Disease Research (JPND)

GERMANY. WCPT COUNTRY PROFILE December 2018

Where we stand in EFORT

Homeopathy and Anthroposophic Medicine THEIR PLACE IN EUROPEAN HEALTH CARE

Rheumatoid Arthritis Disease Burden and Access to Treatment

Yersiniosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods. Epidemiology

Thomas Karlsson & Esa Österberg National Research and Development Centre for Welfare and Health Alcohol and Drug Research Group P.O.

Global Trade in Lightweight Coated Writing Paper TradeData International Pty Ltd ( Page 1 5/18/2015

German Pharmacies. Figures Data Facts Legal disclosure:

The Current Status of Cardiac Electrophysiology in ESC Member Countries J. Brugada, P. Vardas, C. Wolpert

Cost of Disorders of the Brain in Europe Gustavsson et al. Cost of disorders of the brain in Europe Eur. Neuropsych. (2011) 21,

EU Report. Europe FEBRUARY 2017

Ref: E 007. PGEU Response. Consultation on measures for improving the recognition of medical prescriptions issued in another Member State

Risk perception and food safety: where do European consumers stand today?

SOITC Press Ad FAQs. Q: When will these Terms and Conditions changes come into effect?

Trichinellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

EUVAC.NET A surveillance network for vaccine-preventable diseases

Media Release. Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences

Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

We are here for our fellow patients

Screening inside the European Parliament

Alcohol in Europe and Brief Intervention. Dr Lars Møller Programme Manager World Health Organization Regional Office for Europe

Changes to Australian Government Hearing Services Program and Voucher scheme

CAA and SAC 2017 Fall Meeting with the Federal Healthcare Partnership

COMMITTEE OF EXPERTS ON THE CLASSIFICATION OF MEDICINES AS REGARDS THEIR SUPPLY (CD-P-PH/PHO) PROGRAMME RESULTS

Perspectives from regions: successes and challenges in promoting seasonal influenza vaccine usage in the EU

European Parliament Interest Group on CAM Brussels, 16 November 2010

Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013

ALCOHOL CONSUMPTION IN EUROPE; TRADITIONS, GENERATIONS, CULTURE AND POLICY

Cancer drug costs and payment issues in European countries.

Engagement in language assessment / Regions of Europe

Economic Impact of hearing loss: the different systems of hearing management

Authors: Jennifer Kates (Kaiser Family Foundation), Eric Lief (The Stimson Center), Carlos Avila (UNAIDS).

Johns Hopkins individualized Health Initiative

Drug Consumption Rooms Worldwide

THE CVD CHALLENGE IN NORTHERN IRELAND. Together we can save lives and reduce NHS pressures

Drinking guidelines used in the context of early identification and brief interventions in Europe: overview of RARHA survey results

Estimating Smoking Related Cause of Death: a Cohort Approach Based on Lung Cancer Mortality in six European Countries

MEDICINES SHORTAGES PGEU GPUE. John Chave - Secretary general. Pharmaceutical Group of European Union Groupement Pharmaceutique de l Union Européenne

Hana Ross, PhD American Cancer Society and the International Tobacco Evidence Network (ITEN)

Reflecting on ten years of progress in the fight against AIDS, TB and malaria

The cancer burden in the European Union and the European Region: the current situation and a way forward

Finnish international trade 2017 Figures and diagrams. Finnish Customs Statistics

Monthly measles and rubella monitoring report

FORUM FOR AEROSPACE NDT BOARDS

Finnish international trade 2017 Figures and diagrams. Finnish Customs Statistics

Research paper: Legal treatment of the use of cannabis for medical purposes in the member states of the European Union

Where do EU Contries set the limit for low risk drinking.

Hearing Loss: The Statistics

Current levels and recent trends in health inequalities in the EU: Updates from the EU Report

COMMISSION OF THE EUROPEAN COMMUNITIES

The EHRA White Book 2009 The Current Status of Cardiac Electrophysiology in ESC Member Countries J. Brugada, P. Vardas, C. Wolpert

A new scale to measure tobacco control activity in a country: data tables and questionnaire

Allied Health: Sustainable Integrated Health Care for all Australians

NHS or Private Hearing Aids? Find out which option is right for you with the Hearing Information Service s consumer guide.

REPORT ON LAWS AND RECOMMENDATIONS ON DENTAL MERCURY MANAGEMENT IN THE EU

Alcohol-related harm in Europe and the WHO policy response

CHRODIS Kick-off. Communication and Dissemination. Cristina Chiotan / Anna Gallinat Public Health Coordinator / Communications Assistant

Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from Donor Governments in 2011

ICT4Life. Final Conference. Exploitation : a strategic approach based on iterative testing for real market. Isabella Notarangelo (HOPE)

Standards of Care in Epilepsy Current Access to Basic Epilepsy Care Across the European Union

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

Transcription:

Creating a barrier-free Europe for all hard of hearing citizens State of provision of Hearing Aids in Europe 2018 Report 1

Executive Summary Dear Reader, We are pleased to share the report examining affordability of s provision to an individual with hearing loss in Europe. The report is a direct result of the ESSEN DECLARATION 2015 1 and the need to gain a better overview of access to s in Europe. With the Declaration in mind, we have launched a survey to look closely at the evidence of how hard of hearing people in Europe are supported when it comes to obtaining s. Our main focus was on the provision of s for adults but we have included additional information related to provision for children. The Declaration calls for European governments to guarantee access to affordable, good quality, professionally approved s, Assistive Listening Devices, as well as the training and support standards to use them successfully. It builds on the UN Convention on Rights of People with Disabilities and it stated: For 51 million hard of hearing people in the European Union this right can be best fulfilled through state-funded provision of s and the proliferation of assistive listening devices (ALD). What does state-funded provision mean in practice? In the EU, we have state-funded, universal or other means of reimbursement for s. While there are different methods of receiving reimbursement, they all have something in common; they are often part of health policies endorsed by the state. In practical terms it means that all Member States need to ensure that cost is not a barrier to opportunities for hard of hearing citizens. Provision of s is only the first basic step, we need to ensure the provision is following quality standards and the users of the services are offered follow up care including counselling. We have not looked at those additional services in this report as we have focused on reimbursement of s only. It would be advisable to compare additional services that are provided to s users. EFHOH Board 1 https://efhoh.org/wp-content/uploads/2017/04/essen-declaration-2015.pdf 2

THE FINDINGS The service delivery varies across Europe and the responses showed some countries health systems simple to navigate and others quite complex. In Europe many countries have national health / systems, where all citizens pay a tax towards provision of health services. We also have countries who operate based systems, for example Belgium and the Netherlands. In general we see in Europe a certain level of reimbursement, often covering the lower end of s fully and other, higher priced s are partially covered. This system can provide choice, control of service received for users and have short referral /assessment s. For the countries where there is national health with universal coverage such as the United Kingdom, hard of hearing people are not able to exercise choice of the device, even at the lower end of devices as the decision to purchase particular brands is with health managers. This system can have drawbacks with little or no choice and a drown-out effect when getting through referrals and assessments. Provision of s is only the first basic step, we need to ensure the provision is following quality standards and the users of the services are offered follow up care including counselling. Involving users in planning care and enabling them to make their own informed choices we can gain better efficiency of the health system. For this reason understanding variations across Europe as well as examples of good practice can be a catalyst for better investment in hearing care across Europe. Varied access to s and hearing care is a cause for concern as it can present a barrier to independent living and an improved quality of life. It is positive to see some countries putting hearing care and reimbursement in high priority of national health plans but more needs to be done. It is however not acceptable when a person who needs two hearing aids receives help with 1 only and it is also not acceptable to have a 6 months or longer wait to receive help with hearing loss. Recent report by health economist Dr.Laurence Hartman 2 has made a clear case for improved hearing care access. According to the report the cost of untreated hearing loss in Europe is 178 Billion per year. For every Euro that is spent in hearing care, governments get 10 Euro in return (reduced overall cost of untreated hearing loss). Hearing care has a positive effect on quality of life at reasonable direct costs and results in net savings to society. European public health policy should consider hearing loss as one of the major concern in its action plan. 2 https://www.aea-audio.org/portal/index.php/aea-action-plan/intervention 3

ACCESS TO HEARING AIDS IN EUROPE The EU s reimbursement questionnaire 2017 EFHOH questionnaire was sent out to all EFHOH members and other associations in the European countries. The questionnaire was returned by 17 out of 28 Member States and 1 Non-EU Member (Switzerland). 1. Organisation and country you represent. 2. Is there any support in paying for s in your country? e.g. free healthcare, reimbursement, partial reimbursement etc (Please provide as much information as possible about different ways that a can be paid for) 3. Is there a health system in your country that pays for healthcare treatment i.e. health? [Please provide as much information as possible, and include information about whether is mandatory or optional if it exists] 4. Under the reimbursement / state support system in your country, who makes the referral? 5. Is the reimbursement applied at the point of purchase or you must pay full cost first? 6. Is there a limit in the type of you can receive via the state support in your country? 7. What happens if the hard of hearing person wants a that is not covered by state support? [E.g. are they able to pay for it? And are they able to reclaim some of the cost? 8. How long must a person wait for their first? 9. If your hearing worsens and requires a upgrade, how long does this take to happen? Is the upgrade free? 10. What happens when a person loses or breaks the s? Can he/she get a new one without paying? 11. Is for s in the case of theft, loss or damage available to purchase in your country? Can it be included on other policies? 4

THE REFERAL SYSTEMS AND GETTING FIRST HEARING AID Country Referral route Healthcare system Austria ENT for the first medical prescription. No new medical prescription mandatory for renewal. Health Belgium ENT Czech Republic ENT, audiologist Health rules. 660 for one, 1188 for two + 20% VAT. Special provision for people working in difficult noisy environment or due to special audiological requirements : up to 1750 for one, 3150 for two + 20% VAT. Adults: 671 for one, 1329 for two. Children: 1145 for one, 2269 for two Maximal partial reimbursement depended on age and hearing loss: Adults limit: One HA 188 (hearing loss of more than 80 db). One HA 144 (hearing loss 60-79 db), Ones HA 100 (hearing loss less 59 db) only one side (second not covered) Pay up allowed? (reimburse ment) Choice of the HA/ solution? Waiting for the first Up to a few weeks, providing they are on a national database with 2-3 types of HA to choose from with no trial. No waiting No waiting Denmark ENT for hearing tests and referral. Then 2 tracks: Public health care or health care Public: Free of charge Private: Fixed amount for reimbursem ent Children: 2 s covered in similar levels as for adults Public : Free of charge Private: (2018 rate): 1st ear: 552 2 nd ear: 318 Pay up often needed for the purchase, full choice in purchase. No. In public provision with limited choice from approved list. Private: Short waiting Public: Between 2-28 months. Average waiting : 1 year and 2 months. 5

Country Referral route Healthcare system Germany family doctor referral to the Hearing Aid Acoustition (Hörakustiker) Self referral to the Hearing Aid Acoustition (Hörakustiker) ENT for the first medical prescription, no new prescription needed for renewal. 1. Maximum reimbursement applied at the point of purchase - for Moderate Hearing Loss: 734 - for Severe Hearing Loss: 787 Subsequently full reimbursement upon application possible 2. reimbursement in sector depends on individual contract Pay up allowed? Choice of the HA/ solution? Waiting for the first No waiting Greece ENT Social security 450 for one, no coverage for two Up to a few weeks Hungary Self-referral to hearing dispenser or audiologist Social security 70% reimbursement on devices on approved list No waiting Italy Ireland GP, self-referral to audiologist Social security Luxemburg ENT 640 per ear (at 65dBHL avg Hearing Loss). For loss of hearing due to working conditions, provided free of charge (35db) No waiting 500 Euros per ear No informatio n For one ear: Class 1: 800, Class 2: 1.000, Class 3: 1.200. For two ears: Class 1: 1440, Class 2: 1.800, Class 3: 2.160. Class defined by Audiology Expertise Group (Service de Audiophonologique) No information No waiting Netherlands General Practitioner or self-referral to professional Mandatory health Patient contribution is between 0% to 25% towards reimbursement the pays the rest. Private market (outside national protocol) no reimbursement Children free yes, providing they are on approved national database Around 7 days 6

Country Referral route Healthcare system Norway ENT refers for new s Health Government covers most or all of the costs for almost every for citizens with a few exceptions. Pay up allowed? but in practice not needed Choice of the HA/ solution?. Almost all hearing aids are covered Waiting for the first Around 6 months Free s and accessories for hearing loss due to approved occupational injuries. Poland Audiologist / ENT Free s and accessories for under 18 Adults: 160 per ear Children: 460 per ear Extra funds available from disabled peoples fund No waiting Portugal ENT to prescribe HA Market free acoustician provides the s No partial reimbursement, free (100%) if government financed. Government employees can buy on free market with 630 reimbursement per ear, every 5 years. No Free healthcar e, no choice Up to 1 year, sector has no waiting Romania ENT 220 30 days- 2 years Slovenia ENT Adults entitled to 2 HA with reimbursement of 299,36-315,12 per Hearing Aid No if Health provision. if 3-6 months Sweden Family doctor, audiologist, hearing aid dispenser 1: free of charge under national 2: free choice (2000 SEK/ 195 reimbursement in Skane, 3000 SEK/ 295 in Stockholm) 3. Private purchases outside free choice are not reimbursed, under free choice., in all cases. On average 90 days Some areas have up to a year waiting list Private provision has no waiting 7

Country Referral route Healthcare system Switzerland ENT, United Kingdom GP, audiologist, ENT, self-referral in sector both with or contract with NHS Adults: 840 CHF/ 700 for one and 1650 CHF / 1409 for two Children: 1600 CHF/ 1367 for one and 2400 CHF / 2050 for two and extra for batteries and repair 1. Free on NHS at lower end and with dispenser under contact with NHS. 2.no reimbursement in sector Pay up allowed? Choice of the HA/ solution? Waiting for the first No waiting N/A None on NHS, full choice on sector 18 weeks 8

Country applied at point of purchase? AFTER THE FITTING AND FOLLOW UP Minimum length of wait for upgrade against loss/ theft Coverage for repairs Austria 5 years Private, by national health Belgium 4 years Private coverage Private coverage Czech Republic 5 years No, 2 years manufacturer warranty Denmark when buying 4 years Private: Private Public health: Replacement free of charge Finland N/A No information, for purchase. May have to pay costs personally May have to cover costs personally on national system France Depending on 4 years No ( optional) source of reimbursement Germany, for first 6 years, some policies also Greece 4 years No Hungary No information No information No information Italy 5 years, can be part of Ireland No information 4 years No information Luxemburg 5 years No information Manufacturers warranty Netherlands 5 years Some acousticians offer their own coverage for both Norway 6 years, there is. HLF has a special fund for members covering lost/ broken s replacement Poland 5 years No Portugal Usually no reimbursement at point of purchase Slovenia 6 years There is an but premium are high 5 years Lack of information Manufacturer s warranty, when under warranty but may contribute 50% cost with national health provision 9

Country applied at point of purchase? Minimum length of wait for upgrade against loss/ theft Coverage for repairs Romania 5 years No Private policies Sweden, under free choice. None when 4-5 years Possible with free choiceneed regular. May have to pay if national provided hearing aids United Kingdom N/A 3 years Only in sector, not applicable to NHS Depends on county Not applicable to NHS provision. Private provision is under manufacturer s warranty Switzerland No, refunded after purchase 6 years Offered by supplier or companies 2 year guarantee, some coverage from national 10